Yang et al. suggested that JADE2 mRNA was elevated in NSCLC, but our data (Figure 2A) and subsequent analysis of the TCGA datasets (Figure 2B,C) show that overall JADE2 mRNA is either not affected or significantly downregulated in NSCLC tumors. The gene discussed is JADE2; the disease is non-small cell lung carcinoma.